HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data.

AbstractContext:
Anemia and thyroid dysfunction often co-occur, and both increase with age. Human data on relationships between thyroid disease and anemia are scarce.
Objective:
To investigate the cross-sectional and longitudinal associations between clinical thyroid status and anemia.
Design:
Individual participant data meta-analysis.
Setting:
Sixteen cohorts participating in the Thyroid Studies Collaboration (n = 42,162).
Main Outcome Measures:
Primary outcome measure was anemia (hemoglobin <130 g/L in men and <120 g/L in women).
Results:
Cross-sectionally, participants with abnormal thyroid status had an increased risk of having anemia compared with euthyroid participants [overt hypothyroidism, pooled OR 1.84 (95% CI 1.35 to 2.50), subclinical hypothyroidism 1.21 (1.02 to 1.43), subclinical hyperthyroidism 1.27 (1.03 to 1.57), and overt hyperthyroidism 1.69 (1.00 to 2.87)]. Hemoglobin levels were lower in all groups compared with participants with euthyroidism. In the longitudinal analyses (n = 25,466 from 14 cohorts), the pooled hazard ratio for the risk of development of anemia was 1.38 (95% CI 0.86 to 2.20) for overt hypothyroidism, 1.18 (1.00 to 1.38) for subclinical hypothyroidism, 1.15 (0.94 to 1.42) for subclinical hyperthyroidism, and 1.47 (0.91 to 2.38) for overt hyperthyroidism. Sensitivity analyses excluding thyroid medication or high levels of C-reactive protein yielded similar results. No differences in mean annual change in hemoglobin levels were observed between the thyroid hormone status groups.
Conclusion:
Higher odds of having anemia were observed in participants with both hypothyroid function and hyperthyroid function. In addition, reduced thyroid function at baseline showed a trend of increased risk of developing anemia during follow-up. It remains to be assessed in a randomized controlled trial whether treatment is effective in reducing anemia.
AuthorsDaisy M Wopereis, Robert S Du Puy, Diana van Heemst, John P Walsh, Alexandra Bremner, Stephan J L Bakker, Douglas C Bauer, Anne R Cappola, Graziano Ceresini, Jean Degryse, Robin P F Dullaart, Martin Feller, Luigi Ferrucci, Carmen Floriani, Oscar H Franco, Massimo Iacoviello, Georgio Iervasi, Misa Imaizumi, J Wouter Jukema, Kay-Tee Khaw, Robert N Luben, Sabrina Molinaro, Matthias Nauck, Kushang V Patel, Robin P Peeters, Bruce M Psaty, Salman Razvi, Roger K Schindhelm, Natasja M van Schoor, David J Stott, Bert Vaes, Mark P J Vanderpump, Henry Völzke, Rudi G J Westendorp, Nicolas Rodondi, Christa M Cobbaert, Jacobijn Gussekloo, Wendy P J den Elzen, Thyroid Studies Collaboration
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 103 Issue 10 Pg. 3658-3667 (10 01 2018) ISSN: 1945-7197 [Electronic] United States
PMID30113667 (Publication Type: Journal Article, Meta-Analysis, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Topics
  • Anemia (complications, physiopathology)
  • Cross-Sectional Studies
  • Follow-Up Studies
  • Humans
  • Hyperthyroidism (complications, physiopathology)
  • Hypothyroidism (complications, physiopathology)
  • Longitudinal Studies
  • Prognosis
  • Thyroid Function Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: